 |
|
Hyperkalemia in Hospitalized Patients
Causes, Adequacy of Treatment, and Results of an Attempt to Improve Physician Compliance With Published Therapy Guidelines
Christopher G. Acker, MD;
John P. Johnson, MD;
Paul M. Palevsky, MD;
Arthur Greenberg, MD
Arch Intern Med. 1998;158:917-924.
Background Hyperkalemia is a common, potentially life-threatening disorder. Electrocardiograms are considered to be sensitive indicators of the presence of hyperkalemia. Since the treatment of hyperkalemia involves relatively few maneuvers and because its success can be objectively scored, we investigated how physicians manage this disorder and how successful their prescribed therapy is. We also sought to determine whether treatment could be improved by providing the treating physicians with therapy guidelines on a real-time basis.
Methods Consecutive patients with hyperkalemia were identified by review of laboratory records. During the observation-only phase of the study, demographic data, contributing causes, electrocardiogram findings, treatments used, compliance with prescribing guidelines, and patient outcome were recorded. During the subsequent notification phase of the study, treatment recommendations were sent to the patient's ward when the elevated potassium value was noted. The same outcome data were collected.
Results There were 127 episodes of hyperkalemia during the observation-only phase and 115 during the notification phase. No patients died or had life-threatening cardiac arrhythmias. Electrocardiographic abnormalities consistent with hyperkalemia were observed in only 14% of episodes. Renal failure (77%), drugs (63%), and hyperglycemia (49%) contributed to most episodes. Treatments used were exchange resin (51%), insulin (46%), calcium (36%), bicarbonate (34%), and albuterol (4%). The agents were equally efficacious. The time to first treatment was shorter in patients with potassium levels of 6.5 mmol/L or more than in patients with lower values (2.1±2.2 vs 2.8±2.4 hours; P<.05). Treatment was better in the intensive care unit than on regular wards. Only 39% of episodes during the observation-only period met the predetermined criteria for monitoring and diagnosis, initial treatment, and follow-up. During the notification period, physician performance was no better; only 42% of episodes met all criteria. The laboratory transmitted a copy of the guidelines to the patient's ward only 38% of the time. In a separate analysis of these episodes, there was no improvement in treatment. Physicians who did not receive the notification fulfilled all treatment criteria more often than physicians who did (50% vs 30%; P<.05).
Conclusions Although treatment of hyperkalemia was frequently suboptimal, no serious arrhythmias and no deaths complicated management of 242 episodes of severe hyperkalemia. A narrowly targeted effort to improve physician management of a disorder with discrete treatment options did not improve therapy.
From the Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center (Drs Acker, Johnson, Palevsky, and Greenberg), and the Medical Service, Pittsburgh Veterans Affairs Health Care System (Dr Palevsky), Pittsburgh, Pa. Dr Greenberg is now with the Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, NC.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Retrospective Review of the Frequency of ECG Changes in Hyperkalemia
Montague et al.
CJASN 2008;3:324-330.
ABSTRACT
| FULL TEXT
Factors Associated with Time to Follow-up of Severe Hyperkalemia in the Ambulatory Setting
Moore et al.
American Journal of Medical Quality 2007;22:428-437.
ABSTRACT
Possible Metoprolol-Induced Hyperkalemia
Hawboldt and McGrath
Journal of Pharmacy Practice 2006;19:320-325.
ABSTRACT
Follow-up of Markedly Elevated Serum Potassium Results in the Ambulatory Setting: Implications for Patient Safety.
Moore et al.
American Journal of Medical Quality 2006;21:115-124.
ABSTRACT
Hyperkalemia: A Review
Evans and Greenberg
J Intensive Care Med 2005;20:272-290.
ABSTRACT
Managing Hyperkalemia Caused by Inhibitors of the Renin-Angiotensin-Aldosterone System
Palmer
NEJM 2004;351:585-592.
FULL TEXT
Practice corner: the first symptom of hyperkalaemia is death
Glasziou
Evid. Based Med. 2004;9:8-9.
FULL TEXT
Absence of adverse outcomes in hyperkalemic patients undergoing vascular access surgery: [Absence de complications chez des patients hyperkaliemiques devant subir une intervention chirurgicale d'acces vasculaire]
Olson et al.
Canadian J. Anesthesia 2003;50:553-557.
ABSTRACT
| FULL TEXT
Effect of a Computerized Alert on the Management of Hypokalemia in Hospitalized Patients
Paltiel et al.
Arch Intern Med 2003;163:200-204.
ABSTRACT
| FULL TEXT
Management of Severe Hypokalemia in Hospitalized Patients: A Study of Quality of Care Based on Computerized Databases
Paltiel et al.
Arch Intern Med 2001;161:1089-1095.
ABSTRACT
| FULL TEXT
Indications for Hospitalization of Patients With Hyperkalemia
Charytan and Goldfarb
Arch Intern Med 2000;160:1605-1611.
ABSTRACT
| FULL TEXT
|
